Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertapenem 3 vs 7 Days in Penetrating Abdominal Trauma
NCT01203046Phase 3Completed
- Start
- Dec 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of ertapenem in surgical site infection (SSI) (2 arms). Primary endpoint: Surgical Site Infection at 10 days. Started Dec 2010; status: completed.
02
Drugs
ertapenem
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT01203046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01203046.